In order to evaluate the occurrence of hemostatic disorders, 37 patients with transient ischemic attacks (TIAs) and 50 control subjects were studied by means of the Hemostatic Balance Index (H.B.I.) derived from Raby's Thrombo dynamic Potential Index (T.P.I.) and Fearnley's Whole Blood Diluted Lysis Time (W.B.D.L.T.). Results showed a significant increase in T.P.I. and a ten dency to a decrease in fibrinolytic activity in the TIA group: H.B.I. was shown to be significantly increased, thus indicating a pro-thrombotic imbalance in these patients. The occurrence of similar changes in TIA females when com pared to male patients marks the importance of plasmatic factors in the mech anism of thrombotic disorders in females with cerebrovascular disease.
Get full access to this article
View all access options for this article.
References
1.
Danta G.: Second phase platelet aggregation induced by ADP in patients with cerebral vascular disease and in control subjects. Thromb Diath Haemorr23: 159, 1970.
2.
Couch JR, Hassanein RS: Platelet aggregation, stroke and TIAS in middle-aged and elderly patients . Neurology26: 888-895, 1976.
3.
Andersen LA, Gormsen J.: Platelet aggregation and fibrinolytic activity in transient cerebral ischemia . Acta Neurol Scan55: 76-83, 1976.
4.
Al Mefty O., et al: Transient Ischemic Attacks due to increased platelet aggregation and adhesiveness. J Neurosurg50: 449-453, 1979.
Sorensen P., et al: Prognostic value of in vitro measurements of platelet aggregability and fibrinolytic activity in patients with reversible cerebral ischemic attacks . Eur Neurol22: 437-441, 1983.
7.
Uchiyama M., et al: Platelet function tests in thrombotic cerebrovascular disorders . Stroke14: 511-517, 1983.
8.
Arnetoli G., Accardi R., Lippi G.: Blood coagulation abnormalities in Transient Ischemic Attacks: a study of 79 patients (39 carotid and 40 vertebrobasilar). Giorn It Angiol4: 157-165, 1984.
9.
Yamamoto M., Watanabe K., Ando Y.: Clinical significance in the measurement of Beta-Thromboglobulin. Clin Haematol20: 227, 1978.
10.
Hoogendjjk EM, et al: Spontaneous platelet aggregation in cerebrovascular disease. II. Further classification of the platelet defect . Thromb Haemostas41: 512-522, 1979.
11.
Matuda T., et al: Comparison between plasma levels of Beta-Thromboglobulin and Platelet Factor 4 in various diseases. Thromb Haemostas42: 288, 1979.
12.
Fisher M., et al: Marker proteins of platelet activation in patients with cerebrovascular disease. Arch Neurol39: 692-695, 1985.
13.
Stewart ME, et al: Prognosis value of Beta-Thromboglobulin in patients with transient cerebral ischemia. Lancet2:479-481, 1983.
14.
Taomoto K., et al: Usefulness of the measurement of plasma Beta-Thromboglobulin in cerebrovascular diseases. Stroke14: 518-524, 1983.
Walsh PN, et al: Platelet coagulant activities and serum lipids in transient cerebral ischemia. New Eng J Med14: 854-858, 1976.
17.
Mettinger KL , et al: Factor VIII Related Antigen, Anti-thrombin III, Spontaneous platelet aggregation and Plasminogen Activator in ischemic cerebrovascular disease-A study of stroke before 55. J Neurol Sci41: 31-38, 1979.
18.
Wahlberg TB , Blomback M., Overmark I.: Blood coagulation studies in 45 patients with ischemic cerebrovascular disease and 44 patients with venous thromboembolic disease. Acta Med Scand207: 385-390, 1980.
19.
Hartert H.: Die Thromboelastografie. Eine methode zur physikalischen analyse des blutgerinnungsvorganges . Z Exper Med117: 189, 1951.
20.
Hartert H.: Thrombelastography. In: Thrombosis and bleeding disorders. Theory and method. Ed. by Bang NU, Beller FK, Deutsc E, Manner EF. Acad Press, New York, 1971, p. 70.
21.
Tsubokura A. : Application and evaluation of Thrombelastography in determination of fibrinolytic and coagulation function tests. JapJ Clin Pathol19 Suppl: 53-54, 1971.
22.
Biggs R.: Human blood coagulation. Hemostasis and Thrombosis. Blackwell , Oxford, 1972, p. 289.
23.
Balsamo V., et al: Special uses of Thrombelastographic technic in the study and diagnosis of coagulopathies. Minerva Pediatr28: 335-340, 1976.
24.
Duraffourd P.: Les conditions de la fiabilité et les avantages du thrombelastogramme. Coeur12: 447-455, 1981.
25.
Wròblewski M.: Thrombelastographic studies of blood coagulation and fibrinolytic disorders in obstetrics and gynecology. Rocz Akad Med Bjalymstoku16: 115-157, 1971.
26.
Balsamo V., Macaione D., Mancuso G.: Thrombelastography in thrombopenic syndromes in children. Minerva Pediatr27: 572-573, 1975.
27.
Haid M., et al: Thrombelastographic changes in carcinoma: an animal model. J Med7: 189-216, 1976.
28.
McKee LCJr: Thrombelastographic distinction of malignant and benign breast masses . South Med J70: 773, 1977.
29.
Pliutto AM: Determination of the fibrinolytic activity of blood by the method of thrombelastography . Lab Delo9: 569, 1976.
30.
Cherkasov IS , Shibinskaia NI, Nakhabina TP: Thrombelastographic indices in primary glaucoma . Oftalmol Zh33: 264-266, 1978.
31.
Kotovshchikova MA, Federova ZD: Diagnostic value of thrombodynamic potential in blood coagulation disorders. Probl Gematol Pereliv Krovi23: 57-59, 1978.
32.
Gavrilov AO , Shilov AM: Characteristics of the thrombelastogram indices of the arterial and venous blood in acute myocardial infarct. Probl Gematol Pereliv Krovi24: 27-29, 1979.
33.
Kojma K., et al: Thrombelastographic studies in diabetics. Nippon Ganka Gakkai Zasshi82: 715-723, 1978.
34.
Riedel H., Burkert W.: Determination of blood coagulation in acute obstetrical and gynecologic hemorrhages by means of the Hellige direct writing thrombelastograph. Fortschr Med96: 1800-1803, 1978.
35.
Kikkawa T., et al: Factor VIII-related antigen and thrombelastogram in diabetic rethinopathy. Nippon Ganka Gakka Zasshi83: 1408-1415, 1979.
36.
Lee BY, et al: Monitoring heparin therapy with thrombelastography and activated partial thromboplastin time. World J Surg4: 323-330, 1980.
37.
Koslik S., et al: The validity of thrombelastographic examination in patients with chronic renal insufficiency. Vnitr Lek28: 1091-1101, 1982.
38.
Doni A., et al: Hemostasis disorders in 510 cases of neoplasia: a retrospective study. Chemioterapia2: 78-82, 1983.
39.
Vesel'skii ISH: Diagnostic significance of Thromboelastography in acute disorders of cerebral circulation. Vrach Delo7: 26-29, 1973.
40.
Ettinger MG: Thrombelastographic studies in cerebral infarction. Stroke5: 350-354, 1974.
41.
Muggeo M., et al: Parametri emocoagulativi, fibrinolitici e reologici nelle vasculopatie. Effetti della Pentossifillina nel trattamento della vasculopatia acuta cerebrale . La Ricerca Clin Lab11, Suppl: 353-371, 1981.
42.
Fearnley GR, Balmforth G., Fearnley E.: Evidence for diurnal fibrinolytic system with a simple method of measuring natural fibrinolysis. Clin Sci16: 645, 1957.
43.
Leoncini G. , Lippi G., Doni A.: A proposed index to evaluate the hemostatic balance. J ResLab Med1: 75-76, 1983.
44.
Millikan CH , et al: A classification and outline of cerebrovascular disease. II. Stroke6: 564-616, 1975.
45.
Raby C.: La coagulation intravasculaire disséminée et localisé. Masson et CIE Ed 1974.
46.
Bansal BC, et al: Serum lipids, platelets and fibrinolytic activity in cerebrovascular disease. Stroke9: 137-139, 1978.
47.
Tengborn L. , et al: Coagulation studies in children and young adults with cerebral ischemic episodes. Acta Neurol Scand63: 351-361, 1981.
48.
CanadianCooperative Study Group: A randomized trial of Aspirin and Sulphinpyrazone in threatened stroke. New Eng J Med299: 53-59, 1978.
49.
Harris A., et al: Prevention of thrombo-embolic disease by Aspirin. A controlled prospective trial in patients with total hip replacement. New Eng J Med297: 1246-1249, 1977.
